
New Implantable Heart Attack Detection and Warning System Advances Care for High-risk Acute Coronary Syndrome Patients
Avertix’s Guardian™ System, the first and only implantable device approved by the U.S. Food and Drug Administration (FDA) for use in patients who have had prior acute coronary syndrome (ACS) events...